Three Cases of Erythema Multiforme Developed during Deflazacort Therapy in Children with Nephrotic Syndrome.
10.3339/jkspn.2014.18.2.123
- Author:
Seung Jin LEE
1
;
Bong Hwa KANG
;
Min Hyun CHO
Author Information
1. Department of Pediatrics, Kyungpook National University School of Medicine, Daegu, South Korea. chomh@knu.ac.kr
- Publication Type:Case Report
- Keywords:
Erythema multiforme;
Stevens-Johnson syndrome;
Nephrotic syndrome;
Deflazacort
- MeSH:
Adrenal Cortex Hormones;
Child*;
Erythema Multiforme*;
Genitalia;
Humans;
Membranes;
Mortality;
Mouth;
Necrosis;
Nephrotic Syndrome*;
Skin;
Stevens-Johnson Syndrome
- From:Journal of the Korean Society of Pediatric Nephrology
2014;18(2):123-127
- CountryRepublic of Korea
- Language:English
-
Abstract:
Erythema multiforme (EM) is an acute mucocutaneous disorder involving the skin, mouth, eyes, and genital organs. It is classified into EM minor and EM major according to the involvement of the mucosal membrane. Stevens-Johnson syndrome (SJS) and toxic epidermal necrosis (TEN) belong to EM major. Compared to EM minor, SJS presents with more severe and progressive symptoms, and has a higher mortality rate. Corticosteroids are used in the treatment of EM. We report three cases of EM (two cases of EM minor and one case of SJS) that developed during treatment with oral corticosteroid (deflazacort; Calcort(R)) in children with nephrotic syndrome.
